MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • anielle jellin

    Collectif Urgence Toxida

    Mauritius

  • Annapoorani Mercy

    RAINBOW TB FORUM

    India

  • Anthonee Marie Joelle

    Mauritius

  • Antisida de Extremadura Comité

    CAEX

    Spain

  • aparicio veronica karina

    Argentina

  • Appleton Claire

    Hepatitis Australia

    Australia

  • Arancibia Andrea

    Hepatitis C 2000

    Argentina

  • Araujo Reinaldo

    Autônomo

    Brazil

  • Araújo Talita

    Brazil

  • Argiles Vives Jose Mª

    DIAGNOSTICO POR LA IMAGEN ARGILES/VIVES

    Spain

  • Arias Marcon Maria Dolores

    Asscat

    Spain

  • Aronson Bob

    Organ Transplant Initiative (OTI)

    United States

  • Arora Vikas

    Jodhpur School Of Public Health

    India

  • ARRODS Marc

    France

  • Arsalo Ali

    Kevi Consulting

    Finland

  • ARTABE EVA

    Spain

  • Arteaga Flores Frank Evelio

    MANODIVERSA

    Bolivia

  • arumningtyas ramadhani

    LARAS Foundation

    Indonesia

  • Asaeva Alena

    ARF

    Russia

  • asatiani rostom

    "rubiconi"

    Georgia

  • Ashe Elene

    United States

  • Atakli Alex

    Long Life Africa

    Ghana

  • Ateighechi Ismail

    Indian Harm Reduction Net work (IHRN)

    India

  • Audrey-Anne Boustany

    France

  • Aumond Catherine

    AIDES

    France

  • Aung Aung Mya Thida

    Medicine Du Monde

    Burma

  • Aung Myo Thant

    Myanmar Positive Group (National PLHIV Network)

    Burma

  • Aung Myo Thant

    Myanmar Positive Group (National PLHIV Nettwork)

    Burma

  • Aurélien Beaucamp

    Aides

    France

  • Av. Gomes Pereira 98, 4º GAT Grupo de Activistas do Tratamento VIH/SIDA

    1500-332 Lisbon

    Portugal

  • Azkoaga Yrzelai Juan Pedro

    ATEHNA

    Spain

  • Azongo Nyaaba-Aweeba

    Save Your Liver Foundation

    Ghana

  • azuba mombunza

    CONERELA+

    Congo-Kinshasa

  • backstrom shaun

    unaffiliated

    United States

  • Badambayeva Valeriya

    Kazakhstan

  • Bagdasarova Elena

    Ukraine

  • Bagdasarova Olena

    Ukraine

  • bahtout zakaria

    ITPC MENA

    Morocco

  • Baiges Planas Siscu

    Vicepresidente de SICOM

    Spain

  • Bain Tanya

    HIV & HCV Education Project, The University of Queensland

    Australia

  • Bakke Joy

    Canada

  • Balanchivadze Nino

    Alternative Georgia

    Georgia

  • Baldoni Eugênio

    Brazil

  • Ballesteros Juan Carlos

    Spain

  • Balmanya Pomareda Claudi

    Asscat

    Spain

  • Baratashvili Maiko

    Z.Danelia's Union Tanadgoma

    Georgia

  • Barbakadze Rusudan

    Georgia

  • Barker george

    Aurora Project Lambeth

    United Kingdom

  • Barnard Yvonne

    Hepatitis C Global Initiatives

    United States

  • barra vivas paloma

    omsida

    Spain